KEAP1 and hepatocellular carcinoma: In line with this report, a K67 derivate has demonstrated its efficacy in inhibiting phospho-p62-Keap1 interaction in the Huh-7 HCC cell line, overcoming in vitro resistance to chemotherapeutic agents [142].